Surface shape reconstruction from phaseless scattered acoustic data using a random forest algorithm
Johnson, Michael-David, Krynkin, Anton, Dolcetti, Giulio, Alkmim, Mansour, Cuenca, Jacques, De Ryck, Laurent
Published in The Journal of the Acoustical Society of America (01.08.2022)
Published in The Journal of the Acoustical Society of America (01.08.2022)
Get full text
Journal Article
LC3-Associated Phagocytosis in Myeloid Cells Promotes Tumor Immune Tolerance
Cunha, Larissa D., Yang, Mao, Carter, Robert, Guy, Clifford, Harris, Lacie, Crawford, Jeremy C., Quarato, Giovanni, Boada-Romero, Emilio, Kalkavan, Halime, Johnson, Michael D.L., Natarajan, Sivaraman, Turnis, Meghan E., Finkelstein, David, Opferman, Joseph T., Gawad, Charles, Green, Douglas R.
Published in Cell (04.10.2018)
Published in Cell (04.10.2018)
Get full text
Journal Article
Specificity of NifEN and VnfEN for the Assembly of Nitrogenase Active Site Cofactors in Azotobacter vinelandii
Pérez-González, Ana, Jimenez-Vicente, Emilio, Gies-Elterlein, Jakob, Salinero-Lanzarote, Alvaro, Yang, Zhi-Yong, Einsle, Oliver, Seefeldt, Lance C., Dean, Dennis R., Johnson, Michael David Leslie
Published in mBio (31.08.2021)
Get full text
Published in mBio (31.08.2021)
Journal Article
Exposure of the Calcaneus in the Sinus Tarsi Approach Versus the Lateral Extensile Approach: A Cadaveric Study
Prather, John, Wilson, John, Abyar, Eildar, Young, Sean, McGwin, Gerald, Crocker, Caitlin Curtis, Patch, David Albert, Johnson, Michael David
Published in Foot and ankle specialist (26.07.2022)
Published in Foot and ankle specialist (26.07.2022)
Get more information
Journal Article
Effect of phosphotidylinositol 3-kinase-delta inhibitor idelalisib (GS-1101) on signaling in primary non-Hodgkin lymphoma cells: Correlative studies from NCT01306643
Arita, Adriana, Hanlon, Katherine, Chkourko, Halina, Lannutti, Brian Joseph, Johnson, David Michael, Gabrilove, Janice Lynn, Scigliano, Eileen, Parekh, Samir S., Brody, Joshua
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
A phase II study of the selective phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor idelalisib (GS-1101) in combination with rituximab (R) in treatment-naive patients (pts) ≥65 years with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
O'Brien, Susan Mary, Lamanna, Nicole, Kipps, Thomas J., Flinn, Ian, Zelenetz, Andrew David, Burger, Jan Andreas, Holes, Leanne, Johnson, David Michael, Gu, Jessie, Dansey, Roger D., Dubowy, Ronald L., Coutre, Steven E.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Final results of a phase I study of idelalisib (GSE1101) a selective inhibitor of PI3Kδ, in patients with relapsed or refractory CLL
Brown, Jennifer R., Furman, Richard R., Flinn, Ian, Coutre, Steven E., Wagner-Johnston, Nina D., Kahl, Brad S., Spurgeon, Stephen Edward Forbes, Benson, Don M., Peterman, Sissy, Johnson, David Michael, Li, Daniel, Dansey, Roger D., Jahn, Thomas Michael, Byrd, John C.
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
A phase III, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib (GS-1101) in combination with bendamustine and rituximab for previously treated indolent non-Hodgkin lymphomas (iNHL)
De Vos, Sven, Sehn, Laurie Helen, Mulligan, Stephen P., Dreyling, Martin H., Rummel, Mathias J., Zinzani, Pier Luigi, Johnson, David Michael, Evans, Shelley, Dansey, Roger D., Godfrey, Wayne R., Czuczman, Myron Stefan
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article